DCM
DXCM icon

Driehaus Capital Management’s DexCom DXCM Stock Holding History

Driehaus Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-2,792
Closed -$258K – 459
2020
Q4 		$258K Sell
2,792
-4,256
-60% -$380K ﹤0.01% 403
2020
Q3 		$726K Buy
7,048
+856
+14% +$89.4K 0.01% 305
2020
Q2 		$628K Buy
6,192
+344
+6% +$30.8K 0.02% 306
2020
Q1 		$394K Sell
5,848
-852
-13% -$53K 0.01% 313
2019
Q4 		$366K Buy
6,700
+16
+0.2% +$759 0.01% 438
2019
Q3 		$249K Buy
+6,684
New +$260K 0.01% 454
2019
Q2 		– Sell
-13,240
Closed -$394K – 484
2019
Q1 		$394K Buy
13,240
+6,184
+88% +$217K 0.01% 335
2018
Q4 		$211K Sell
7,056
-19,896
-74% -$631K 0.01% 392
2018
Q3 		$964K Buy
+26,952
New +$836K 0.03% 356
2017
Q2 		– Sell
-62,732
Closed -$1.33M – 565
2017
Q1 		$1.33M Buy
62,732
+27,912
+80% +$545K 0.05% 327
2016
Q4 		$520K Sell
34,820
-97,188
-74% -$1.72M 0.02% 411
2016
Q3 		$2.89M Sell
132,008
-59,048
-31% -$1.31M 0.1% 217
2016
Q2 		$3.79M Buy
191,056
+72,224
+61% +$1.23M 0.14% 163
2016
Q1 		$2.02M Sell
118,832
-80,496
-40% -$1.34M 0.07% 280
2015
Q4 		$4.08M Sell
199,328
-191,440
-49% -$3.98M 0.14% 173
2015
Q3 		$8.39M Sell
390,768
-47,852
-11% -$1.07M 0.3% 79
2015
Q2 		$8.77M Sell
438,620
-43,760
-9% -$769K 0.3% 78
2015
Q1 		$7.52M Sell
482,380
-370,040
-43% -$5.59M 0.26% 97
2014
Q4 		$11.7M Buy
852,420
+54,920
+7% +$672K 0.47% 43
2014
Q3 		$7.97M Sell
797,500
-204,752
-20% -$2.09M 0.3% 78
2014
Q2 		$9.94M Sell
1,002,252
-330,064
-25% -$2.92M 0.32% 69
2014
Q1 		$13.8M Sell
1,332,316
-501,652
-27% -$5.19M 0.43% 52
2013
Q4 		$16.2M Buy
1,833,968
+997,576
+119% +$7.89M 0.59% 31
2013
Q3 		$5.9M Buy
836,392
+133,416
+19% +$845K 0.23% 143
2013
Q2 		$3.94M Buy
+702,976
New +$3.37M 0.17% 181

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Driehaus Capital Management's DXCM Position: Q1 2021 in Review

Driehaus Capital Management sold out of DexCom (DXCM) in Q1 2021, closing a stake of 2,792 shares — an estimated $258K sold.

Driehaus Capital Management first reported a position in DXCM in Q2 2013 and held it in 25 quarters. The position peaked at $16.2M in Q4 2013. 730 funds tracked by Wall St. Rank hold DXCM as of Q1 2021.

  • Driehaus Capital Management reported no remaining DexCom position as of Q1 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 2,792 DexCom shares in Q1 2021, an estimated $258K.
  • Driehaus Capital Management first reported a position in DexCom in Q2 2013 and held it in 25 quarters.
  • Driehaus Capital Management's DexCom position peaked at $16.2M in Q4 2013.
  • 730 funds tracked by Wall St. Rank held DexCom as of Q1 2021.

Based on Driehaus Capital Management's 13F filing for Q1 2021, filed 17 May 2021.